Article Cited by others

ORIGINAL ARTICLE

Antiarrhythmic drug usage and prostate cancer: a population-based cohort study

Kao Li-Ting, Huang Chung-Chien, Lin Herng-Ching, Huang Chao-Yuan

Year : 2018| Volume: 20| Issue : 1 | Page no: 37-42

   This article has been cited by
 
1 Digoxin reduces the incidence of prostate cancer but increases the cancer-specific mortality: A systematic review and pooled analysis
Shankun Zhao,Xin Li,Weizhou Wu,Shixiong Liu,Maolei Shen,Zuzhao Zhang,Jian He
Andrologia. 2021;
[Pubmed]  [Google Scholar] [DOI]
2 Multifaceted anti-colorectal tumor effect of digoxin on HCT8 and SW620 cells in vitro
Yong-Qiang Hou,Ying-Ying Wang,Xing-Can Wang,Yao Liu,Chun-Ze Zhang,Zhe-Sheng Chen,Zhe Zhang,Wei Wang,De-Xin Kong
Gastroenterology Report. 2020;
[Pubmed]  [Google Scholar] [DOI]
3 The Functional Role of Voltage-Gated Sodium Channel Nav1.5 in Metastatic Breast Cancer
Qianxuan Luo,Ting Wu,Wenfang Wu,Gong Chen,Xuan Luo,Liping Jiang,Huai Tao,Mingqiang Rong,Shuntong Kang,Meichun Deng
Frontiers in Pharmacology. 2020; 11
[Pubmed]  [Google Scholar] [DOI]
4 Association Between the Overall Risk of Prostate Cancer and Use of Calcium Channel Blockers: A Systematic Review and Meta-Analysis
Hui Yang,Yahui Yu,Xiaopeng Hu,Wei Wang,Xiaoyong Yang,Hang Liu,Liang Ren,Xiaodong Zhang,Xin Feng,Lihong Liu
Clinical Therapeutics. 2020;
[Pubmed]  [Google Scholar] [DOI]
5 In Vivo Evidence for Voltage-Gated Sodium Channel Expression in Carcinomas and Potentiation of Metastasis
Mustafa B. A. Djamgoz,Scott P. Fraser,William J. Brackenbury
Cancers. 2019; 11(11): 1675
[Pubmed]  [Google Scholar] [DOI]
6 Antihypertensive drugs and prostate cancer risk in a Finnish population-based cohort
Aino Siltari,Teemu J. Murtola,Kirsi Talala,Kimmo Taari,Teuvo L J. Tammela,Anssi Auvinen
Scandinavian Journal of Urology. 2019; : 1
[Pubmed]  [Google Scholar] [DOI]

 

Read this article